2023 (v1)
Publication
Purpose: To evaluate the impact of pasireotide (PAS) therapy on hormonal and glycometabolic outcome in patients with acromegaly previously treated with combination medical therapies or unconventional dosages of first-generation somatostatin receptor ligands (fg-SRLs). Methods: Retrospective study carried out in two referral centers for...
Uploaded on: February 14, 2024